From: Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use
All patients (n = 90) | Abdominal pain n (%) | NSAID usage n (%) | ESR mm/h range (median) elevated (n) | FC ÎĽg/g range (median) elevated (n) |
---|---|---|---|---|
JIA patients | ||||
Oligoarthritis (33) | 13 (39%) | 15 (45%) | 1–80 (12) n = 15 | 1–368 (17) n = 5 |
Polyarthritis (29) | 11 (38%) | 14 (48%) | 1–94 (16) n = 15 | 2–1617 (34) n = 7 |
JSpA* (8) | 1 (13%) | 5 (63%) | 10–35 (19) n = 4 | 11–184 (18) n = 1 |
All JIA (70) | 27 (39%) | 34 (70%) | 1–94 (15) n = 34 (49%) | 1–1617 (25) n = 13 (19%) |
Arthralgia (20) | 12 (60%) | 12 (60%) | 7–50 (10) n = 7 (35%) | 0–113 (32) n = 1 (5%) |